Kye Young Lee

8.5k total citations · 1 hit paper
118 papers, 3.7k citations indexed

About

Kye Young Lee is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Cancer Research. According to data from OpenAlex, Kye Young Lee has authored 118 papers receiving a total of 3.7k indexed citations (citations by other indexed papers that have themselves been cited), including 73 papers in Pulmonary and Respiratory Medicine, 38 papers in Oncology and 30 papers in Cancer Research. Recurrent topics in Kye Young Lee's work include Lung Cancer Treatments and Mutations (40 papers), Lung Cancer Research Studies (21 papers) and Cancer Genomics and Diagnostics (17 papers). Kye Young Lee is often cited by papers focused on Lung Cancer Treatments and Mutations (40 papers), Lung Cancer Research Studies (21 papers) and Cancer Genomics and Diagnostics (17 papers). Kye Young Lee collaborates with scholars based in South Korea, United States and China. Kye Young Lee's co-authors include Jian Hua Shi, Yi‐Long Wu, Yang Shi, Mei Hou, Shun Lü, Sarayut Lucien Geater, Wěi Li, Chengping Hu, Dan Massey and Yunchao Huang and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Clinical Oncology and PLoS ONE.

In The Last Decade

Kye Young Lee

111 papers receiving 3.7k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Afatinib versus cisplatin plus gemcitabine for first-line treatment of Asian patients with advanced non-small-cell lung cancer harbouring EGFR mutations (LUX-Lung 6): an open-label, randomised phase 3 trial

2014 1.6k citations Yi‐Long Wu, Caicun Zhou et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Kye Young Lee South Korea	26	2.4k	1.8k	1.4k	989	189	118	3.7k
Jennifer L. Spratlin Canada	24	1.2k 0.5×	2.0k 1.1×	1.4k 1.0×	767 0.8×	189 1.0×	92	3.6k
Toshiyuki Kamoto Japan	37	1.6k 0.7×	840 0.5×	1.4k 1.0×	602 0.6×	156 0.8×	262	3.9k
Humam Kadara United States	34	914 0.4×	1.1k 0.6×	1.8k 1.3×	900 0.9×	172 0.9×	95	3.2k
Feng Zhao China	24	785 0.3×	861 0.5×	1.2k 0.9×	322 0.3×	163 0.9×	76	2.4k
Christopher D. Coldren United States	24	1.1k 0.5×	653 0.4×	1.3k 0.9×	485 0.5×	166 0.9×	36	2.7k
Tao Jiang China	41	2.7k 1.1×	3.2k 1.8×	1.7k 1.3×	1.0k 1.0×	315 1.7×	176	5.5k
Faruk Taş Türkiye	26	563 0.2×	1.5k 0.8×	978 0.7×	435 0.4×	204 1.1×	172	2.9k
Qingyuan Zhang China	31	631 0.3×	1.4k 0.8×	1.3k 0.9×	778 0.8×	200 1.1×	141	3.0k
Edward Gabrielson United States	31	965 0.4×	1.0k 0.6×	1.6k 1.1×	1.0k 1.0×	256 1.4×	59	3.4k
Jin S. Lee United States	30	960 0.4×	1.2k 0.7×	1.3k 1.0×	466 0.5×	343 1.8×	60	3.4k

Countries citing papers authored by Kye Young Lee

Since Specialization

Citations

This map shows the geographic impact of Kye Young Lee's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kye Young Lee with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kye Young Lee more than expected).

Fields of papers citing papers by Kye Young Lee

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kye Young Lee. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kye Young Lee. The network helps show where Kye Young Lee may publish in the future.

Co-authorship network of co-authors of Kye Young Lee

This figure shows the co-authorship network connecting the top 25 collaborators of Kye Young Lee. A scholar is included among the top collaborators of Kye Young Lee based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kye Young Lee. Kye Young Lee is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Park, Cheol‐Kyu, Seung Joon Kim, Chan Kwon Park, et al.. (2024). Real‐world outcome of crizotinib for anaplastic lymphoma kinase‐positive lung cancer: Multicenter retrospective analysis in South Korea. Thoracic Cancer. 15(6). 448–457. 2 indexed citations

Kim, Jin Joo, Kyung Jin Nam, Kye Young Lee, et al.. (2024). Multiparametric MRI assessment of primary tumours for predicting axillary tumour burden in women with invasive breast cancer. British Journal of Radiology. 98(1167). 432–440.

Lee, Jae Cheol, In‐Jae Oh, Eun Young Kim, et al.. (2024). Real-World Outcomes of Crizotinib in ROS1-Rearranged Advanced Non-Small-Cell Lung Cancer. Cancers. 16(3). 528–528. 5 indexed citations

Kim, In Ae, Jae Young Hur, Hee Joung Kim, Wan Seop Kim, & Kye Young Lee. (2023). A prospective phase 2 study of expeditious EGFR genotyping and immediate therapeutic initiation through extracellular vesicles (EV)-based bronchoalveolar lavage fluid (BALF) liquid biopsy in advanced NSCLC patients. Translational Lung Cancer Research. 12(7). 1425–1435. 4 indexed citations

Kim, In Ae, Jae Young Hur, Hee Joung Kim, et al.. (2020). Targeted Next-Generation Sequencing Analysis for Recurrence in Early-Stage Lung Adenocarcinoma. Annals of Surgical Oncology. 28(7). 3983–3993. 25 indexed citations

Kim, Dong‐Min, et al.. (2018). Fluorometric detection of EGFR exon 19 deletion mutation in lung cancer cells using graphene oxide. The Analyst. 143(8). 1797–1804. 15 indexed citations

Kim, In Ae, et al.. (2018). Cumulative smoking dose affects the clinical outcomes of EGFR-mutated lung adenocarcinoma patients treated with EGFR-TKIs: a retrospective study. BMC Cancer. 18(1). 768–768. 17 indexed citations

Park, Cheol‐Kyu, In‐Jae Oh, Kyu-Sik Kim, et al.. (2017). Randomized Phase III Study of Docetaxel Plus Cisplatin Versus Pemetrexed Plus Cisplatin as First-line Treatment of Nonsquamous Non–Small-cell Lung Cancer: A TRAIL Trial. Clinical Lung Cancer. 18(4). e289–e296. 18 indexed citations

Lee, Seung Eun, et al.. (2016). Detection of EGFR and KRAS Mutation by Pyrosequencing Analysis in Cytologic Samples of Non-Small Cell Lung Cancer. Journal of Korean Medical Science. 31(8). 1224–1224. 9 indexed citations

10.

Geater, Sarayut Lucien, Chong‐Rui Xu, Caicun Zhou, et al.. (2015). Symptom and Quality of Life Improvement in LUX-Lung 6: An Open-Label Phase III Study of Afatinib Versus Cisplatin/Gemcitabine in Asian Patients With EGFR Mutation-Positive Advanced Non–small-cell Lung Cancer. Journal of Thoracic Oncology. 10(6). 883–889. 49 indexed citations

11.

Lee, Sung Yong, Hee Sun Park, Kye Young Lee, et al.. (2013). Paclitaxel-Loaded Polymeric Micelle (230 mg/m2) and Cisplatin (60 mg/m2) vs. Paclitaxel (175 mg/m2) and Cisplatin (60 mg/m2) in Advanced Non–Small-Cell Lung Cancer: A Multicenter Randomized Phase IIB Trial. Clinical Lung Cancer. 14(3). 275–282. 23 indexed citations

12.

Chung, Hyun Woo, Kye Young Lee, Hee Joung Kim, Wan Seop Kim, & Young So. (2013). FDG PET/CT metabolic tumor volume and total lesion glycolysis predict prognosis in patients with advanced lung adenocarcinoma. Journal of Cancer Research and Clinical Oncology. 140(1). 89–98. 91 indexed citations

13.

Choi, Hye Jin, et al.. (2010). Atypical Thymoma (World Health Organization Type B3) with Neuroendocrine Differentiation Combined with Hyperparathyroidism. Journal of Thoracic Oncology. 5(9). 1490–1491. 3 indexed citations

14.

Lee, Kye Young, et al.. (2006). A Comparative Study on the Effects of Genetic Factors, Smoking and Alcohol Intake on Lung Cancer in Koreans and Korean-Chinese. 6(2). 120–128. 1 indexed citations

15.

Kim, Doh Hyung, Jae‐Hyun Lee, Eun Kyung Choi, et al.. (2002). Chronic Necrotizing Bronchopulmonary Aspergillosis With Elements of Bronchocentric Granulomatosis. The Korean Journal of Internal Medicine. 17(2). 138–142. 4 indexed citations

16.

Jee, Young‐Koo, Hee Yeon Kim, Jae-Suk Park, et al.. (2000). Two-spotted spider mite (Tetranychus urticae): an important allergen in asthmatic non-farmers symptomatic in summer and fall months. Annals of Allergy Asthma & Immunology. 84(5). 543–548. 20 indexed citations

17.

Lee, Kye Young, et al.. (2000). Inhibitory mechanism on NF-kB transactivation by dexamethasone in pulmonary epithelial cells. Tuberculosis and Respiratory Diseases. 48(5). 682–682. 1 indexed citations

18.

Lee, Kye Young, Wenteh Chang, Daoming Qiu, Peter N. Kao, & Glenn D. Rosen. (1999). PG490 (Triptolide) Cooperates with Tumor Necrosis Factor-α to Induce Apoptosis in Tumor Cells. Journal of Biological Chemistry. 274(19). 13451–13455. 166 indexed citations

19.

Park, Gye Young, et al.. (1999). Bronchoscopic findings of endobronchial vascular lesions in patients with haemoptysis. Respirology. 4(4). 401–404. 12 indexed citations

20.

Lee, Jae Ho, Gee Young Suh, Kye Young Lee, et al.. (1992). Small Airway Disease in Rheumatoid Arthritis. The Korean Journal of Internal Medicine. 7(2). 87–94. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact